Iams Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-702
Closed -$754K – 195
2025
Q4
$754K Buy
+702
New +$671K 0.27% 105
2025
Q2
– Sell
-368
Closed -$304K – 183
2025
Q1
$304K Buy
368
+45
+14% +$37.4K 0.14% 138
2024
Q4
$249K Sell
323
-213
-40% -$176K 0.11% 148
2024
Q3
$475K Buy
536
+96
+22% +$86.3K 0.23% 103
2024
Q2
$398K Buy
440
+30
+7% +$24K 0.22% 106
2024
Q1
$311K Buy
+410
New +$292K 0.19% 97

Other funds holding LLY

Iams Wealth Management's LLY Position: Q1 2026 in Review

Iams Wealth Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 702 shares — an estimated $754K sold.

Iams Wealth Management first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $754K in Q4 2025. 4,389 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Iams Wealth Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Iams Wealth Management sold 702 Eli Lilly shares in Q1 2026, an estimated $754K.
  • Iams Wealth Management first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • Iams Wealth Management's Eli Lilly position peaked at $754K in Q4 2025.
  • 4,389 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Iams Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.